| ANOVA | analysis of variance |
| AUC | area under concentration-time curve |
| Cmax | peak plasma concentration |
| CAA | chloroacetaldehyde |
| CL | clearance |
| CTX | cyclophosphamide |
| DCCTX | 2-dechloroethylcyclophosphamide |
| CYP450 | cytochrome P450 |
| DDIs | drug-drug interactions |
| Gom A | gomisin A |
| Gom C | gomisin C |
| HLMs | human liver microsomes |
| IC50 | half maximal inhibitory concentration |
| IS | internal standard |
| Keto | ketoconazole |
| Ki | dissociation constant for reversible inhibition |
| kobs | initial inactivation rate constant |
| kinact | the maximal inactivation rate constant |
| KI | half maximal inhibitory concentration for MBI |
| LLOQ | lower limit of quantification |
| LSD | least significant difference |
| MBI | mechanism-based inhibition |
| MI | metabolite-intermediate |
| MRT | mean residence time |
| NADPH | dihydronicotinamide adenine dinucleotide phosphate |
| NADPH-gs | NADPH regenerating system |
| PBS | potassium phosphate buffer |
| SCE | Schisandra chinensis extract |
| SD | standard deviation |
| t1/2 | terminal half-life |
| Tes | testosterone |
| TDI | time-dependent inhibition |
| Tmax | time of plasma concentration reach a maximum |
| TNZ | tinidazole |
| Vmax | maximum reaction rate |
| Vd | apparent volume of distribution |
| 6OH-Tes | 6β-hydroxytestosterone. |